AACR Annual Meeting 2023: Therapy Advances for Patients With Rare Melanoma Types
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
Category: Research
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
When teacher Ellen Reich began treatment for multiple myeloma in 2014, a sequence of therapies approved by the U.S....